Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Encompass Health ( (EHC) ) just unveiled an announcement.
Encompass Health reported strong financial results for the fourth quarter of 2024, with notable revenue growth of 12.7%, driven by a 7.8% increase in discharges and a 4.2% rise in net patient revenue per discharge. Adjusted EBITDA rose by 13.6%, attributed to increased revenue, while operating cash flow surged by 38.7% due to higher net income and favorable working capital changes. The company issued 2025 guidance targeting net operating revenue between $5,800 to $5,900 million and Adjusted EBITDA from $1,160 to $1,200 million, reflecting a positive outlook on its operational strategy and long-term business prospects.
More about Encompass Health
Encompass Health is the largest owner and operator of inpatient rehabilitation hospitals in the United States, with 166 hospitals across 38 states and Puerto Rico. The company provides high-quality rehabilitative care for patients recovering from significant injuries or illnesses, utilizing advanced technology and innovative treatments to maximize recovery.
YTD Price Performance: 10.87%
Average Trading Volume: 617,648
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $10.3B
For detailed information about EHC stock, go to TipRanks’ Stock Analysis page.
